Javier David Benitez Fuentes (Javier David Benítez-Fuentes, Javier David Benítez Fuentes)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 17

Top Topics

Peritoneal Dialysis

Tyrosine Kinase

Respiratory Syndrome Coronavirus

Top Venues

Respirology case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Salvador Gámez-Casado, Javier David Benitez Fuentes, Beatriz Álvarez, Gema García Ledo
Achieving complete metabolic response in stage IV lung adenocarcinoma with chemotherapy, nivolumab, ipilimumab, and salvage SBRT: A case report. Respirology case reports 12 (4) (2024)
Salvador Gámez-Casado, Javier David Benitez Fuentes, Beatriz Álvarez, Gema García Ledo
Achieving complete metabolic response in stage IV lung adenocarcinoma with chemotherapy, nivolumab, ipilimumab, and salvage SBRT: A case report. Respirology case reports 12 (4) (2024)
Kauzar Mohamed Mohamed, Kissy Guevara-Hoyer, Carlos Jiménez García, Laura García Bravo, Adolfo Jiménez-Huete, Antonia Rodríguez de la Peña, Beatriz Mediero Valeros, Cristina Cañizares Velázquez, Esther Culebras López, Noemí Cabello, Vicente Estrada, Ángel L Corbi, Miguel Fernández-Arquero, Alberto Ocaña, Alberto Delgado-Iribarren, Mercedes Martínez-Novillo, Estefanía Bolaños, Eduardo Anguita, Ascensión Peña, Celina Benavente, Javier David Benitez Fuentes, Pedro Pérez Segura, Silvia Sánchez-Ramón
Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors. Biomedicines 11 (4) (2023)
Kauzar Mohamed Mohamed, Kissy Guevara-Hoyer, Carlos Jiménez García, Laura García Bravo, Adolfo Jiménez-Huete, Antonia Rodríguez de la Peña, Beatriz Mediero Valeros, Cristina Cañizares Velázquez, Esther Culebras López, Noemí Cabello, Vicente Estrada, Ángel L Corbi, Miguel Fernández-Arquero, Alberto Ocaña, Alberto Delgado-Iribarren, Mercedes Martínez-Novillo, Estefanía Bolaños, Eduardo Anguita, Ascensión Peña, Celina Benavente, Javier David Benitez Fuentes, Pedro Pérez Segura, Silvia Sánchez-Ramón
Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors. Biomedicines 11 (4) (2023)
Santiago Cabezas-Camarero, Vanesa García-Barberán, Javier David Benitez Fuentes, Miguel J Sotelo, José Carlos Plaza, Alejandro Encinas-Bascones, Óscar De-la-Sen, Farzin Falahat, Jesús Gimeno-Hernández, Manuel Gomez Serrano, Fernando Puebla-Díaz, Manuel De-Pedro-Marina, Maricruz Iglesias-Moreno, Pedro Pérez-Segura
Clinical Behavior, Mutational Profile and T-Cell Repertoire of High-Grade Neuroendocrine Tumors of the Head and Neck. Cancers 15 (9) (2023)
Alicia Milagros de Luna Aguilar, Javier David Benitez Fuentes, Justo Ortega Anselmi, Jennifer Olalla Inoa, Paloma Flores Navarro, Alfonso Lopez de Sá, Jesus Fuentes Antras, Cristina Rodríguez Rey, Aída Ortega Candil, Fernando Moreno Antón, José Angel García-Saenz
Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study. Cancers 15 (18) (2023)
Santiago Cabezas-Camarero, Vanesa García-Barberán, Javier David Benitez Fuentes, Miguel J Sotelo, José Carlos Plaza, Alejandro Encinas-Bascones, Óscar De-la-Sen, Farzin Falahat, Jesús Gimeno-Hernández, Manuel Gomez Serrano, Fernando Puebla-Díaz, Manuel De-Pedro-Marina, Maricruz Iglesias-Moreno, Pedro Pérez-Segura
Clinical Behavior, Mutational Profile and T-Cell Repertoire of High-Grade Neuroendocrine Tumors of the Head and Neck. Cancers 15 (9) (2023)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Paloma Flores Navarro, Alfonso Lopez de Sa Lorenzo, Carmen Toledano Rojas, Berta Laguna Fonseca, Richa Shah, Clara Frick, Alejandro Francisco Jimenez Ortega, Tania Rocha Iñigo, Natalia Vidal Cassinello
Case Report: Bocavirus Infection Radiologically Resembling a Congestive Heart Failure in a Patient with Metastatic Castration-Resistant Prostate Cancer. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Paloma Flores Navarro, Alfonso Lopez de Sa Lorenzo, Carmen Toledano Rojas, Berta Laguna Fonseca, Richa Shah, Clara Frick, Alejandro Francisco Jimenez Ortega, Natalia Vidal Cassinello
Case Report: Bocavirus Infection Radiologically Resembling a Congestive Heart Failure in a Patient with Metastatic Castration-Resistant Prostate Cancer Case-Report. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego-Ellacuría, Pedro Pérez Segura
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain. F1000Research 11 (2022)